Although it was originally assumed that LDHC was strictly present in the testes, several studies have been published that LDHC is present in a range of cancer tissues, including lung cancer (47%), melanoma (44%), breast cancer (35%), and some prostate cancers [95]. The gene discussed is LDHC; the disease is prostate carcinoma.